Royal Caribbean Cruises Ltd. (R1CL34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 55.42 |
|---|---|
| 52-week range | 41.20 – 67.14 |
| Return, 1 month / 3 months | +24.5% / +7.5% |
| Return, 1 year / 3 years | +8.8% / +413.7% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 57.1% |
| Worst drawdown (1 year) | -31.1% |
| Average daily value traded | 0.02M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Royal Caribbean Cruises Ltd. is a cruise company that operates holiday voyages at sea. Its ships carry passengers on itineraries to destinations such as the Caribbean, Alaska, Europe and Asia, and the fleet includes vessels marketed under its main cruise brands. The company serves leisure travellers and also operates private island destinations used on its itineraries. It is incorporated in Liberia and runs its business from headquarters in Miami, Florida, in the United States.
Royal Caribbean Cruises Ltd. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code R1CL34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Royal Caribbean Cruises Ltd. (R1CL34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 55.42 on 27 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 843 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.8% and over the last three months it rose 7.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.3% | ||
| From 52-week high | -17.5% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.5% | ||
| 6-month return | 29.7% | ||
| 12-month return, skipping the last month | -12.6% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.1% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M BRL | ||
| Zero-volume days | 10.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +24.5% |
| 3 months | +7.5% |
| 6 months | +29.7% |
| 1 year | +8.8% |
| 3 years | +413.7% |
| 5 years | +382.7% |
Signals
| 50-day / 200-day average | 50.05 / 50.25 |
|---|---|
| Golden / death cross (60 days) | Death, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | USD 52.4675 |
| 4 Mar 2026 | USD 52.2798 |
| 22 Dec 2025 | USD 36.4185 |
| 23 Sep 2025 | USD 36.8365 |
| 2 Jun 2025 | USD 27.6720 |
| 5 Mar 2025 | USD 29.8661 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.